Understanding the COVID-19 Vaccine Policy Terrain in Ontario Canada: A Policy Analysis of the Actors, Content, Processes, and Context

Author:

AlShurman Bara’ Abdallah1ORCID,Tetui Moses123,Nanyonjo Agnes4,Butt Zahid Ahmad1ORCID,Waite Nancy M.2ORCID,Vernon-Wilson Elizabeth2ORCID,Wong Ginny2,Grindrod Kelly2

Affiliation:

1. School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, ON N2L 3G5, Canada

2. School of Pharmacy, University of Waterloo, Kitchener, ON N2G 1C5, Canada

3. Department of Epidemiology and Global Health, Umeå University, 907 37 Umeå, Sweden

4. Lincoln International Institute for Rural Health, University of Lincoln, Brayford Way, Brayford, Pool, Lincoln LN6 7TS, UK

Abstract

(1) Background: Canada had a unique approach to COVID-19 vaccine policy making. The objective of this study was to understand the evolution of COVID-19 vaccination policies in Ontario, Canada, using the policy triangle framework. (2) Methods: We searched government websites and social media to identify COVID-19 vaccination policies in Ontario, Canada, which were posted between 1 October 2020, and 1 December 2021. We used the policy triangle framework to explore the policy actors, content, processes, and context. (3) Results: We reviewed 117 Canadian COVID-19 vaccine policy documents. Our review found that federal actors provided guidance, provincial actors made actionable policy, and community actors adapted policy to local contexts. The policy processes aimed to approve and distribute vaccines while continuously updating policies. The policy content focused on group prioritization and vaccine scarcity issues such as the delayed second dose and the mixed vaccine schedules. Finally, the policies were made in the context of changing vaccine science, global and national vaccine scarcity, and a growing awareness of the inequitable impacts of pandemics on specific communities. (4) Conclusions: We found that the triad of vaccine scarcity, evolving efficacy and safety data, and social inequities all contributed to the creation of vaccine policies that were difficult to efficiently communicate to the public. A lesson learned is that the need for dynamic policies must be balanced with the complexity of effective communication and on-the-ground delivery of care.

Funder

British Academy

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference136 articles.

1. The global fiscal response to COVID-19: Risks and repercussions;Makin;Econ. Anal. Policy,2021

2. OECD Policy Responses to Coronavirus (COVID-19) (2022, May 19). The Territorial Impact of COVID-19: Managing the Crisis and Recovery across Levels of Government. Available online: https://www.oecd.org/coronavirus/policy-responses/the-territorial-impact-of-covid-19-managing-the-crisis-and-recovery-across-levels-of-government-a2c6abaf/.

3. Health Canada (2021, November 08). Health Canada Authorizes First COVID-19 Vaccine, Available online: https://www.canada.ca/en/health-canada/news/2020/12/health-canada-authorizes-first-covid-19-vaccine0.html.

4. An Inconsistent Canadian Provincial and Territorial Response During the Early COVID-19 Pandemic;Cyr;Front. Public Health,2021

5. Government of Canada (2021, November 19). Canada’s Health Care System, Available online: https://www.canada.ca/en/health-canada/services/canada-health-care-system.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3